Related references
Note: Only part of the references are listed.Spinal circRNA-9119 Suppresses Nociception by Mediating the miR-26a-TLR3 Axis in a Bone Cancer Pain Mouse Model (November, 10.1007/S12031-019-01378-W, 2019)
Zhongqi Zhang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2020)
Enhanced expression of circ_0000735 forecasts clinical severity in NSCLC and promotes cell progression via sponging miR-1179 and miR-1182
Wei Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
A novel circular RNA, hsa_circ_0043278, acts as a potential biomarker and promotes non-small cell lung cancer cell proliferation and migration by regulating miR-520f
Jinggang Cui et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
Yuting Sang et al.
MOLECULAR THERAPY (2019)
hsa_circRNA_100533 regulates GNAS by sponging hsa_miR_933 to prevent oral squamous cell carcinoma
Xiaoqin Zhu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Potential Role of circPVT1 as a proliferative factor and treatment target in esophageal carcinoma
Rongrong Zhong et al.
CANCER CELL INTERNATIONAL (2019)
CircRNA: a novel type of biomarker for cancer
He-da Zhang et al.
BREAST CANCER (2018)
Circular RNA circ_0001649 acts as a prognostic biomarker and inhibits NSCLC progression via sponging miR-331-3p and miR-338-5p
Tongmiao Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Upregulation of circular RNA hsa_circ_0007534 predicts unfavorable prognosis for NSCLC and exerts oncogenic properties in vitro and in vivo
Yi Qi et al.
GENE (2018)
Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1
Zhu Kun-Peng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer
Dong Hang et al.
CANCER MEDICINE (2018)
Clinical significance of miRNA-106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy
Ye Tian et al.
CANCER BIOLOGY & MEDICINE (2018)
Timeliness of Treatment Initiation and Associated Survival Following Diagnosis of Non-Small-Cell Lung Cancer in South Carolina
Jarrod T. Bullard et al.
SOUTHERN MEDICAL JOURNAL (2017)
Identification and functional characterization of circRNA-0008717 as an oncogene in osteosarcoma through sponging miR-203
Xiang Zhou et al.
Oncotarget (2017)
The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex
Lorena Verduci et al.
GENOME BIOLOGY (2017)
Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer
Jie Chen et al.
CANCER LETTERS (2017)
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Novello et al.
ANNALS OF ONCOLOGY (2016)
Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma
Meilin Qin et al.
CANCER BIOMARKERS (2016)
Circular RNAs are abundant, conserved, and associated with ALU repeats
William R. Jeck et al.
RNA (2013)
Drug therapy: Multidisciplinary management of lung cancer
A Spira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
